Clinical Trial Update: The Improvement of Limbal Stem Cell Deficiency (LSCD) in Unilateral Stem Cell Damage by Amniotic Membrane Extract Eye Drop (AMEED) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Amniotic Membrane Extract Eye Drop (AMEED) for unilateral Limbal Stem Cell Deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limbal Stem Cell Deficiency

Drugs mentioned

• Amniotic Membrane Extract Eye Drop (AMEED) (amniotic membrane extract eye drop)

Snippet

Sponsor: Royan Institute | Conditions: Limbal Stem Cell Deficiency (LSCD) | Phase 1 | Status: COMPLETED